Q2 2015 Holdings
Filed 2015-07-15 | 5 holdings | $78.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $35.8M | 407,416 | 45.4% |
| Five Prime Therapeutics, Inc.(FPRX) | Common Stock | 33830X104 | $27.1M | 1,092,152 | 34.4% |
| Achaogen, Inc. | Common Stock | 004449104 | $7.7M | 1,281,152 | 9.8% |
| Biotie Therapies Corp. | ADS | 09074D103 | $5.4M | 268,672 | 6.8% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $2.8M | 1,048,601 | 3.6% |